Denmark-based diabetes and obesity giant Novo Nordisk says it plans to invest 8.5 billion Danish kroner ($1.2 billion) to ...

UK-based Puretech Health has announced positive results from ELEVATE IPF, a Phase IIb trial of deupirfenidone (LYT-100) at ...

BioNTech resumes its PRESERVE-003 trial for gotistobart as a monotherapy in metastatic squamous NSCLC after a partial ...

VectorY Therapeutics appoints Jim Scibetta as CEO to lead development of VTx-002, a vectorized antibody therapy targeting TDP ...

Shares of Swedish pharma firm Orexo leapt 20.2% to 20.60 kronor this morning, following its announcement over the weekend ...

US biotech Checkpoint Therapeutics saw its shares jump more than 16% to $4.27 in after-hours trading on Friday, on the news ...

The buy will bolster Pharming’s pipeline with Abliva’s lead asset, KL1333, a promising therapy for mitochondrial disease.

At the request of the individual product sponsors, the US Food and Drug Administration (FDA) has revoked the Emergency Use ...

UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael ...

Relation’s 'Lab-in-the-Loop' platform combines human genetics, single-cell multi-omics directly from human tissue, functional ...

News early in last week was dominated by presentations at the American Society of Hematology (ASH) meeting. Among these was ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) adopted positive opinions for six biosimilar medicines ...